T CELL RECEPTORS RECOGNIZING MUTATED P53
Australia
2024227695
Filed on 2024-10-28
2024227695
Filed on 2024-10-28
T CELL RECEPTORS WHICH RECOGNIZE MUTATED EGFR
Australia
2024219754
Filed on 2024-09-16
2024219754
Filed on 2024-09-16
COMPOSITIONS TARGETING GPC2 AND GPC3 AND THEIR USE FOR TREATING SOLID TUMORS
European Patent
23727442.8
Filed on 2024-11-04
23727442.8
Filed on 2024-11-04
T CELL RECEPTORS RECOGNIZING MUTATED P53
Japan
2024-178808
Filed on 2024-10-11
2024-178808
Filed on 2024-10-11
METHODS OF ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR A P53 CANCER-SPECIFIC MUTATION
European Patent
24215129.8
Filed on 2024-11-25
24215129.8
Filed on 2024-11-25
METHODS OF PREPARING CELL THERAPY PRODUCTS FOR THE TREATMENT OF CONDITIONS CAUSED BY HUMAN PAPILLOMAVIRUS 6 OR 11 INFECTION
US Application 63/709,683
Filed on 2024-10-21
Filed on 2024-10-21
CHIMERIC ANTIGEN RECEPTORS TARGETING THE GAMMA DELTA T CELL RECEPTOR
US Application 63/678,625
Filed on 2024-08-02
Filed on 2024-08-02
VIRUS-LIKE PARTICLE CONJUGATES COMPRISING PHOTOACTIVATABLE DYE COMPOUNDS AND METHODS OF MAKING AND USING THE SAME
US Application 63/690,592
Filed on 2024-09-04
Filed on 2024-09-04
CD28 HINGE AND TRANSMEMBRANE CONTAINING CHIMERIC ANTIGEN RECEPTORS TARGETING GPC2 AND USE THEREOF
China
202380034151.6
Filed on 2024-10-14
202380034151.6
Filed on 2024-10-14